Awanish Kumar

Dr. Awanish Kumar

Biotechnology, National Institute of Technology, Raipur, India
orcid
National Institute of Technology, Raipur, India

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2018 in Journal of Environmental Chemical Engineering
Verified
Journal Article
Closed access
Awanish KumarAwanish Kumar
Awanish Kumar
DPDharm Pal
Dharm Pal

30 July 2013 in The Protein Journal
Verified
Journal Article
Closed access
PDF file
GGGopal Jee Gopal
Gopal Jee Gopal
Awanish KumarAwanish Kumar
Awanish Kumar

1 July 2020 in Journal of Functional Foods
Verified
Journal Article
Open access
SBSudhanshu S. Behera
Sudhanshu S. Behera
Aly Farag El SheikhaAly Farag El Sheikha
Aly Farag El Sheikha
Riadh HammamiRiadh Hammami
Riadh Hammami
Awanish KumarAwanish Kumar
Awanish Kumar

16 April 2012 in Chemical Reviews
Verified
Journal Article
Closed access
Awanish KumarAwanish Kumar
Awanish Kumar
PVPannuru Venkatesu
Pannuru Venkatesu

1 October 2016 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
Ashwini KumarAshwini Kumar
Ashwini Kumar
AVArchana Vimal
Archana Vimal
Awanish KumarAwanish Kumar
Awanish Kumar

12 February 2018 in Therapeutic Advances in Endocrinology and Metabolism
Verified
Journal Article
Open access
SBSudhanshu Kumar Bharti
Sudhanshu Kumar Bharti
SKSupriya Krishnan
Supriya Krishnan
Ashwini KumarAshwini Kumar
Ashwini Kumar
Awanish KumarAwanish Kumar
Awanish Kumar
Diabetes Mellitus, characterized by persistent hyperglycaemia, is a heterogeneous group of disorders of multiple aetiologies. It affects the human body at multiple organ levels thus making it difficult to follow a particular line of the treatment protocol and requires a multimodal approach. The increasing medical burden on patients with diabetes-related complications results in an enormous economic burden, which could severely impair global economic growth in the near future. This shows that today’s healthcare system has conventionally been poorly equipped towards confronting the mounting impact of diabetes on a global scale and demands an urgent need for newer and better options. The overall challenge of this field of diabetes treatment is to identify the individualized factors that can lead to improved glycaemic control. Plants are traditionally used worldwide as remedies for diabetes healing. They synthesize a diverse array of biologically active compounds having antidiabetic properties. This review is an endeavour to document the present armamentarium of antidiabetic herbal drug discovery and developments, highlighting mechanism-based antidiabetic properties of over 300 different phytoconstituents of various chemical categories from about 100 different plants modulating different metabolic pathways such as glycolysis, Krebs cycle, gluconeogenesis, glycogen synthesis and degradation, cholesterol synthesis, carbohydrate metabolism as well as peroxisome proliferator activated receptor activation, dipeptidyl peptidase inhibition and free radical scavenging action. The aim is to provide a rich reservoir of pharmacologically established antidiabetic phytoconstituents with specific references to the novel, cost-effective interventions, which might be of relevance to other low-income and middle-income countries of the world.